Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-03-11
2008-03-11
Crane, L. E. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S045000, C514S047000
Reexamination Certificate
active
11414896
ABSTRACT:
Methods and uses are described for treating or preventing diseases of humans or non-human animals by reducing the amount of active leukotriene B4(LTB4) in those in need of such treatment using LTB4hydroxylases. In certain embodiments, LTB4hydroxylase is administered in combination with nicotinamide adenine dinucleotide phosphate and/or an NADPH-cytochrome P-450 reductase. The invention is particularly useful for treating or preventing respiratory diseases that are caused or exacerbated by inflammation.
REFERENCES:
Powell, W.S., J. Biological Chemistry, 1984, vol. 259, No. 5, pp. 3082-3089.
Kawashima, H., Archives of Biochemistry and Biophysics, 1997, vol. 347, No. 1, pp. 148-154.
P. M. O'Byrne, Leukotriene B4 Induces Airway Hyperresponsiveness in Dogs, Journal of Applied Physiology, vol. 59, Issue 6 1941-1946, 1985.
Zsuzsanna Csoma, Increase Leukotrienes in Exhaled Condensate in Childhood Asthma, Am J Respir Crit Care Med, vol. 166. pp. 1345-1349, 2002.
Antczak James B.
Brostrom Lane
Harder David R.
LandOfFree
Methods and uses of leukotriene B 4 hydroxylases to treat... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and uses of leukotriene B 4 hydroxylases to treat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and uses of leukotriene B 4 hydroxylases to treat... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3950365